130 related articles for article (PubMed ID: 12898516)
21. Interactive effects of histone deacetylase inhibitors and TRAIL on apoptosis in human leukemia cells: involvement of both death receptor and mitochondrial pathways.
Shankar S; Singh TR; Fandy TE; Luetrakul T; Ross DD; Srivastava RK
Int J Mol Med; 2005 Dec; 16(6):1125-38. PubMed ID: 16273296
[TBL] [Abstract][Full Text] [Related]
22. Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL.
Altucci L; Rossin A; Raffelsberger W; Reitmair A; Chomienne C; Gronemeyer H
Nat Med; 2001 Jun; 7(6):680-6. PubMed ID: 11385504
[TBL] [Abstract][Full Text] [Related]
23. Regulation of TRAIL-induced apoptosis by ectopic expression of antiapoptotic factors.
Aggarwal BB; Bhardwaj U; Takada Y
Vitam Horm; 2004; 67():453-83. PubMed ID: 15110190
[TBL] [Abstract][Full Text] [Related]
24. N-(4-hydroxyphenyl) retinamide (4HPR) enhances TRAIL-mediated apoptosis through enhancement of a mitochondrial-dependent amplification loop in ovarian cancer cell lines.
Cuello M; Coats AO; Darko I; Ettenberg SA; Gardner GJ; Nau MM; Liu JR; Birrer MJ; Lipkowitz S
Cell Death Differ; 2004 May; 11(5):527-41. PubMed ID: 14765134
[TBL] [Abstract][Full Text] [Related]
25. Epidermal growth factor and trail interactions in epithelial-derived cells.
Gibson SB
Vitam Horm; 2004; 67():207-27. PubMed ID: 15110179
[TBL] [Abstract][Full Text] [Related]
26. COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis.
Yamanaka Y; Shiraki K; Inoue T; Miyashita K; Fuke H; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
Int J Mol Med; 2006 Jul; 18(1):41-7. PubMed ID: 16786154
[TBL] [Abstract][Full Text] [Related]
27. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
[TBL] [Abstract][Full Text] [Related]
28. Hypoxia inhibits tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by blocking Bax translocation.
Kim M; Park SY; Pai HS; Kim TH; Billiar TR; Seol DW
Cancer Res; 2004 Jun; 64(12):4078-81. PubMed ID: 15205314
[TBL] [Abstract][Full Text] [Related]
29. An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice.
Pei Z; Chu L; Zou W; Zhang Z; Qiu S; Qi R; Gu J; Qian C; Liu X
Hepatology; 2004 May; 39(5):1371-81. PubMed ID: 15122766
[TBL] [Abstract][Full Text] [Related]
30. Synergistic inhibition of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human pancreatic beta cells by Bcl-2 and X-linked inhibitor of apoptosis.
Ou D; Wang X; Metzger DL; James RF; Pozzilli P; Plesner A; Korneluk RG; Verchere CB; Tingle AJ
Hum Immunol; 2005 Mar; 66(3):274-84. PubMed ID: 15784465
[TBL] [Abstract][Full Text] [Related]
31. Curcumin differentially sensitizes malignant glioma cells to TRAIL/Apo2L-mediated apoptosis through activation of procaspases and release of cytochrome c from mitochondria.
Gao X; Deeb D; Jiang H; Liu YB; Dulchavsky SA; Gautam SC
J Exp Ther Oncol; 2005; 5(1):39-48. PubMed ID: 16416600
[TBL] [Abstract][Full Text] [Related]
32. Activation of the cAMP signaling pathway increases apoptosis in human B-precursor cells and is associated with downregulation of Mcl-1 expression.
Myklebust JH; Josefsen D; Blomhoff HK; Levy FO; Naderi S; Reed JC; Smeland EB
J Cell Physiol; 1999 Jul; 180(1):71-80. PubMed ID: 10362019
[TBL] [Abstract][Full Text] [Related]
33. Interrelated roles for Mcl-1 and BIM in regulation of TRAIL-mediated mitochondrial apoptosis.
Han J; Goldstein LA; Gastman BR; Rabinowich H
J Biol Chem; 2006 Apr; 281(15):10153-63. PubMed ID: 16478725
[TBL] [Abstract][Full Text] [Related]
34. Mcl-1 is downregulated in cisplatin-induced apoptosis, and proteasome inhibitors restore Mcl-1 and promote survival in renal tubular epithelial cells.
Yang C; Kaushal V; Shah SV; Kaushal GP
Am J Physiol Renal Physiol; 2007 Jun; 292(6):F1710-7. PubMed ID: 17311906
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells.
Kobayashi S; Werneburg NW; Bronk SF; Kaufmann SH; Gores GJ
Gastroenterology; 2005 Jun; 128(7):2054-65. PubMed ID: 15940637
[TBL] [Abstract][Full Text] [Related]
36. Differences in TRAIL-induced changes of Mcl-1 expression among distinct human colon epithelial cell lines.
Vaculová A; Hofmanová J; Zatloukalová J; Kozubík A
Exp Cell Res; 2009 Nov; 315(19):3259-66. PubMed ID: 19782681
[TBL] [Abstract][Full Text] [Related]
37. Epidermal growth factor (EGF) suppresses staurosporine-induced apoptosis by inducing mcl-1 via the mitogen-activated protein kinase pathway.
Leu CM; Chang C; Hu C
Oncogene; 2000 Mar; 19(13):1665-75. PubMed ID: 10763823
[TBL] [Abstract][Full Text] [Related]
38. Mcl-1 interacts with truncated Bid and inhibits its induction of cytochrome c release and its role in receptor-mediated apoptosis.
Clohessy JG; Zhuang J; de Boer J; Gil-Gómez G; Brady HJ
J Biol Chem; 2006 Mar; 281(9):5750-9. PubMed ID: 16380381
[TBL] [Abstract][Full Text] [Related]
39. Herceptin sensitizes ErbB2-overexpressing cells to apoptosis by reducing antiapoptotic Mcl-1 expression.
Henson ES; Hu X; Gibson SB
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):845-53. PubMed ID: 16467098
[TBL] [Abstract][Full Text] [Related]
40. A new quantitative assay for cytochrome c release in apoptotic cells.
Waterhouse NJ; Trapani JA
Cell Death Differ; 2003 Jul; 10(7):853-5. PubMed ID: 12815469
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
